Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

Tag: C-bridge capital

Chinese Healthcare-Focused C-Bridge Capital Gets $50M From US Public Pension Fund

C-Bridge Capital Leads Series B Round In Chinese Pharmaceutical Firm Nuance...

Chinese Biotech Firm Ascletis First To File For Hong Kong IPO...

C-Bridge Capital, BioBAY Lead $38M Series A Round In Biopharmaceutical Service...

China Healthcare Investor Forum 2017

C-Bridge Closes Its Second Healthcare Fund At $400M

Qiming Leads $29M Round In Chinese Antibody Drug Developer Sino Biological

CICC, CITIC To Privatize Chinese Biopharma Firm Sinovac Biotech

Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction

C-Bridge Capital Leads $150M Round In Merged Chinese Drug Developer

C-Bridge’s Fu Wei Aims To Profit By Transferring Pharma Tech To...

C-Bridge Invests $25M In Medical Equipment Maker Anrei

C-Bridge Capital Leads $100M Round In Chinese Drug Start-Up Ascletis

Goldman Sachs Injects $20M In China Biotech Firm Ascletis

C-Bridge Capital Leads $35M New Round In Ascletis

© 2020 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.